室间隔心肌切除联合二尖瓣次级腱索切断术治疗梗阻性肥厚型心肌病的长期结局
该研究评估了350例连续接受室间隔心肌切除联合前二尖瓣叶次级腱索切断术的梗阻性肥厚型心肌病患者长期结果,中位随访5.6年。6年总生存率96%,与年龄性别匹配的意大利一般人群无差异(P=0.331);末次评估时79%患者NYHA I级,≥95%患者无残余左室流出道压差、显著二尖瓣反流或收缩功能受损。
要点
- 联合术式6年总生存率96%,与匹配的一般人群无差异(P=0.331)。
- 随访末79%患者无症状(NYHA I级),仅2%为NYHA III级。
- ≥95%患者无残余流出道压差、显著二尖瓣反流或收缩功能受损。
核心结论
- 在梗阻性肥厚型心肌病中,切断增厚和/或回缩的前二尖瓣叶次级腱索联合室间隔心肌切除具有优异的长期临床和血流动力学结果。
研究设计与样本
- 单中心回顾性长期随访研究,纳入5年期间连续350例接受该联合手术的梗阻性肥厚型心肌病患者,中位随访5.6年(Q1-Q3:4.2-6.3年)。
主要发现
- 包括2例院内死亡(手术死亡率0.6%),术后6年总生存率为96%,与年龄性别匹配的意大利一般人群无差异(P=0.331)。
- 随访信息可获取于344例(99%)患者;末次评估时271例(79%)为NYHA I级,65例(19%)为II级,8例(2%)为III级。
- 随访期间共14例死亡,其中6例与肥厚型心肌病无关。
- 末次超声心动图评估时,≥95%患者无残余左室流出道压差、临床显著二尖瓣反流或收缩功能受损。
临床怎么用
- 对于药物难治性症状严重的梗阻性肥厚型心肌病患者,室间隔心肌切除联合前二尖瓣叶次级腱索切断术可作为外科选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The recent introduction of cardiac myosin inhibitors has modified the therapy of left ventricular outflow obstruction in patients with hypertrophic cardiomyopathy (HCM) and is raising uncertainties regarding the future role of surgery in the management of obstructive HCM. However, it is likely that a proportion of patients will continue to present with advanced, highly symptomatic HCM, despite medical therapy, and require surgical intervention. We previously reported the short-term results of cutting anterior mitral leaflet secondary chordae in combination with septal myectomy in patients with obstructive HCM. This operative approach has shown excellent results in several short-term studies from our and other centers. However, no data are currently available regarding the long-term outcome of this novel surgical procedure. OBJECTIVES: The study sought to investigate the long-term results of myectomy associated with chordal cutting. METHODS: Long-term results were assessed in 350 consecutive patients with obstructive HCM who underwent this operation at our center over a 5-year period. Median follow-up was 5.6 years (Q1-Q3: 4.2-6.3 years). RESULTS: Including 2 in-hospital deaths (surgical mortality 0.6%), 6-year overall survival after surgery was 96% and did not differ from that of the general Italian population matched for age and sex (P = 0.331). Follow-up information was available in 344 (99%) patients. At the most recent evaluation, 271 (79%) patients were asymptomatic in NYHA functional class I, 65 (19%) were in NYHA functional class II, and 8 (2%) were in NYHA functional class III. During follow-up, there were 14 deaths, 6 of which were unrelated to HCM. At most recent echocardiographic evaluation, ≥95% of patients had no residual left ventricular outflow gradient, clinically significant mitral regurgitation, or impaired systolic function. CONCLUSIONS: Our results show that cutting thickened and/or retracted secondary chordae of the anterior mitral leaflet in association with septal myectomy has excellent long-term clinical and hemodynamic results in patients with obstructive HCM. These findings may further increase the number of myectomy referral centers and the availability of the surgical option for severely symptomatic HCM patients unresponsive to medical treatment.
引用
- Ferrazzi P, Spirito P, Binaco I, et al. Long-Term Outcome of Myectomy Associated With Secondary Mitral Valve Chordal Cutting in Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2026. PMID: 42307496. doi:10.1016/j.jacc.2026.04.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。